Cargando…
Real-World Use – Isavuconazole at a Large Academic Medical Center
BACKGROUND: Invasive fungal infections cause significant mortality and morbidity. Isavuconazole (ISV) is a new triazole approved for treatment of mucormycosis and aspergillosis. Data on its effectiveness outside clinical trials and in patients receiving prior triazole prophylaxis are lacking. METHOD...
Autores principales: | Hassouna, HabiBA, Brizendine, Kyle, Athans, Vasilios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631743/ http://dx.doi.org/10.1093/ofid/ofx163.028 |
Ejemplares similares
-
2106. Evaluation of Isavuconazole for the Prophylaxis and Treatment of Invasive Fungal Infections at a Large Academic Medical Center
por: Vu, Christine, et al.
Publicado: (2019) -
1730. Real-World Use Of Dalbavancin In A US Tertiary Referral Center
por: Bhugra, Mudita, et al.
Publicado: (2022) -
Outpatient Antimicrobial Stewardship Intervention Targeting Cytomegalovirus (CMV) Viremia in Solid Organ Transplant (SOT) Recipients
por: Wang, Nan, et al.
Publicado: (2017) -
1810. Therapeutic Drug Monitoring of Azole Antifungals at an Academic Medical Center: Opportunities and Lessons Learned
por: Richardson, Steven, et al.
Publicado: (2018) -
Economic Outcomes of Isavuconazole to Prevent Invasive Fungal Infection in Immunocompromised Adults: Initial Experience at an Academic Medical Center
por: Kowalewska, Christina A, et al.
Publicado: (2017)